The financing was led by Lapam Capital, with participation from Frees Fund and Riverhead Capital.

Chronic kidney disease (CKD) is a progressive condition that begins with tissue damage and gradually leads to loss of kidney ...

A newly engineered antibody can penetrate kidney cysts and interrupt the growth signals that drive polycystic kidney disease.

In-office application of a double layered amniotic membrane is well-tolerated and effective for ocular surface diseases, a case series shows.

Study met its primary endpoint demonstrating that GRI-0621 was well tolerated over 12 weeks of treatment, with no drug-related severe or serious ...

Idiopathic pulmonary fibrosis (IPF) is a chronic disease in which healthy lung tissue is gradually replaced by scar tissue.

Pneumoconiosis remains a prevalent occupational disease with limited treatment options. A new review study elucidates the ...

Background CFTR modulators have transformed cystic fibrosis (CF) treatment, but individual responses vary even among patients with identical CFTR genotypes. This underscores the need for predictive ...

Introduction: Lung cancer is a highly heterogeneous disease, and the tumor microenvironment (TME) characteristics are closely related to disease progression and treatment outcomes. We elucidated the ...